Visp, Switzerland

Lonza Group

Visp and Basel CDMO providing capsules (Capsugel) and nutraceutical contract manufacturing.

Founded in Switzerland in 1897, Lonza is described as the first and original CDMO and serves as a global partner with 20,000 employees across five continents. The company operates through three primary divisions: Integrated Biologics, which provides mammalian development and manufacturing services plus licensing technologies; Advanced Synthesis, delivering small-molecule drug substances, highly potent APIs, bioconjugates, and drug product formulation services with over 125 years of chemistry expertise; and Specialized Modalities, operating at the forefront of mRNA, cell and gene therapy, and microbial technologies. Lonza also manufactures capsules and health ingredients through its Capsugel business unit for pharmaceutical and nutraceutical applications. The company provides comprehensive development services across early-phase work, process development, analytical development, regulatory affairs support, and commercial manufacturing, with specific capabilities including mammalian cell line development, drug substance and drug product manufacturing, formulation development, and manufacturing of clinical trial materials.

Capabilities

Supplements
CapsulesTablets

Tags

Also in Switzerland

Supplements — Capsules

See all in Switzerland →

Similar manufacturers

Also working in Supplements — Capsules